Syneos Health_rgb_r.jpg
Syneos Health Leaders Recognized For Visionary Healthcare Expertise Through HBA
May 06, 2021 07:30 ET | Syneos Health, Inc.
MORRISVILLE, N.C., May 06, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that Lynn Hamilton, Senior...
Syneos Health_rgb_r.jpg
Syneos Health Announces Pricing of Secondary Offering of Common Stock
May 03, 2021 21:33 ET | Syneos Health, Inc.
MORRISVILLE, N.C., May 03, 2021 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization, today...
Syneos Health_rgb_r.jpg
Syneos Health Announces Secondary Offering of Common Stock
May 03, 2021 16:40 ET | Syneos Health, Inc.
MORRISVILLE, N.C., May 03, 2021 (GLOBE NEWSWIRE) -- Syneos Health, Inc. (Nasdaq: SYNH) (the “Company” or “Syneos Health”), the only fully integrated biopharmaceutical solutions organization, today...
Syneos Health_rgb_r.jpg
Syneos Health Launches “Lab to Life” Enterprise Partnership with Komodo Health
May 03, 2021 07:00 ET | Syneos Health, Inc.
MORRISVILLE, N.C., May 03, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, announced today it has expanded its relationship...
Syneos Health_rgb_r.jpg
Illingworth Research Group Recognized with Queen’s Award for Enterprise: International Trade 2021
April 30, 2021 05:05 ET | Syneos Health, Inc.
MORRISVILLE, N.C., April 30, 2021 (GLOBE NEWSWIRE) -- The Illingworth Research Group, a Syneos Health® company, has been recognized with a 2021 Queen’s Award for Enterprise for International Trade....
Syneos Health_rgb_r.jpg
Syneos Health Reports First Quarter 2021 Results
April 29, 2021 06:16 ET | Syneos Health, Inc.
Highlights Revenue of $1,208.7 million for the three months ended March 31, 2021, representing a sequential increase of 6.0% compared to the three months ended December 31, 2020, and a...
Syneos Health_rgb_r.jpg
Syneos Health Partners with Medable, Expanding Decentralized Solutions to Bring Clinical Trials Closer to the Patient
April 20, 2021 09:00 ET | Syneos Health, Inc.
MORRISVILLE, N.C. and PALO ALTO, Calif., April 20, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and Medable, the leading...
Syneos Health_rgb_r.jpg
Syneos Health Schedules First Quarter 2021 Earnings Call for Thursday, April 29, 2021
April 01, 2021 16:01 ET | Syneos Health, Inc.
MORRISVILLE, N.C., April 01, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its first quarter 2021 financial...
Syneos Health_rgb_r.jpg
Syneos Health Partners with Science 37® to Transform Clinical Trials – Increasing Speed and Diversity
March 29, 2021 07:00 ET | Syneos Health, Inc.
MORRISVILLE, N.C. and LOS ANGELES, March 29, 2021 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, and Science 37, the...
Syneos Health_rgb_r.jpg
Syneos Health Communications Boosts Global Creative Capabilities with Renowned Talent
March 15, 2021 09:00 ET | Syneos Health, Inc.
MORRISVILLE, N.C., March 15, 2021 (GLOBE NEWSWIRE) -- Syneos Health Communications – the portfolio of Syneos Health® agencies designed to deliver insights-driven integrated communications spanning...